Echoiq Limited has released a press release.
Management Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from EchoIQ
- Completion of US Reader Study
- Receipt of Research & Development Tax Incentive
- Appendix 4D 31 December 2023
- RSH: Cardiovascular AI platform integrated into RPM program
- EIQ Licenses Software to Respiri - Remote Patient Mon.
Later from EchoIQ
- Appendix 4C Cash Flow Report
- Quarterly Report
- US FDA Application Lodged
- Echo IQ Commences New Heart Failure Clinical Study Using AI
- Investor Presentation
Follow EchoIQ into a list and get an email when it puts out news.
Follow EchoIQ